Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs

Despite the success of imatinib in advanced gastrointestinal stromal tumor (GIST) patients, 50% of the patients experience resistance within two years of treatment underscoring the need to get better insight into the mechanisms conferring imatinib resistance. Here the microRNA and mRNA expression pr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Amirnasr, Azadeh, Gits, Caroline M.M., van Kuijk, Patricia F., Smid, Marcel, Vriends, Anne L.M., Rutkowski, Piotr, Sciot, Raf, Schöffski, Patrick, Debiec-Rychter, Maria, Sleijfer, Stefan, Wiemer, Erik A. C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627192/
https://ncbi.nlm.nih.gov/pubmed/31238586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060882
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller